Dermira (DERM) Misses Q4 EPS by 13c

Dermira (NASDAQ: DERM) reported Q4 EPS of ($0.60), $0.13 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $16 million versus the consensus estimate of $16.57 million.

For earnings history and earnings-related data on Dermira (DERM) click here.

You May Also Be Interested In

• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• Bernstein upgrades Analog Devices on Q3 beat, improving risk-reward
• Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance